Corticosteroid-induced osteoporosis prevention: Longitudinal practice patterns in The Netherlands 2001-2005

Osteoporosis International

Volumn 18, Issue 10, 2007, Pages 1429-1433

  Duyvendak, M ^a,b   Naunton, M ^a,b,c   Atthobari, J ^b,d   Van Den Berg, P B ^b,d   Brouwers, J R B J ^a,b,d  

^a Tjongerschans Hospital   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c CHARLES DARWIN UNIVERSITY   (Australia)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Corticosteroids; Osteoporosis; Prescribing patterns; Prevention; The Netherlands

Indexed keywords

ANTIASTHMATIC AGENT; ANTIVITAMIN K; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ESTROGEN; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROGESTERONE; PROTON PUMP INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG SUBSTITUTION; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OSTEOPOROSIS; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

ADRENAL CORTEX HORMONES; AGED; ANTIRHEUMATIC AGENTS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; OSTEOPOROSIS; PREDNISOLONE; SEX FACTORS; TREATMENT OUTCOME;

EID: 34548592249     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0345-9     Document Type: Article

References (12)

1. Canalis E, Bilezikian JP, Angeli A, Giustina A (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-598
2. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
3. Curtis JR, Westfall AO, Allison JJ et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485-2494
4. Feldstein AC, Elmer PJ, Nichols GA, Herson M (2005) Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int 16:2168-2174
5. Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD (2004) Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol 31:550-556
6. Osteoporose Tweede Herziene Richtlijn [Osteoporosis, Second Revised Guideline] (2002) ISBN 90-76906-23-8, 2nd ed. Utrecht: Van Zuiden Communications B.V.
7. World Health Organization. The WHO Collaborating Centre for Drug Statistics Methodology: http://www.whocc.no/atcddd/ (accessed February 2006)
8. Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL (2006) Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 33:1651-1657
9. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C (2000) Use of oral corticosteroids in the United Kingdom. QJM 93:105-111
10. Walsh LJ, Wong CA, Pringle M, Tattersfield AE (1996) Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344-346
11. Yood RA (2006) Prevention of glucocorticoid-induced osteoporosis: why are we doing so poorly? J Rheumatol 33:1461-1463
12. Newman ED, Matzko CK, Olenginski TP et al (2006) Glucocorticoid-Induced Osteoporosis Program (GIOP): a novel, comprehensive, and highly successful care program with improved outcomes at 1 year. Osteoporos Int 17:1428-1434